AX
Axos Financial Inc.
Company Overview
| Mkt Cap | $4.59B | Price | $87.38 |
| Volume | 65.41K | Change | +1.52% |
| P/E Ratio | 10.6 | Open | $86.56 |
| Revenue | $1.2B | Prev Close | $86.07 |
| Net Income | $432.9M | 52W Range | $67.89 - $101.92 |
| Div Yield | N/A | Target | $110.17 |
| Overall | 49 | Value | 60 |
| Quality | 52 | Technical | 36 |
No chart data available
About Axos Financial Inc.
Axos Financial, Inc., together with its subsidiaries, provides consumer and business banking products in the United States. It operates through two segments, Banking Business and Securities Business. It offers deposits products, including consumer and business checking, savings, time deposit, and commercial and deposits. The company also provides residential single family, multifamily, and commercial mortgage loans; commercial real estate secured, commercial and industrial non-real estate, and auto and consumer loans. In addition, it offers various investment and wealth management services, such as disclosed clearing, recordkeeping, trade reporting, and reorganization assistance services, as well as margin loans and securities lending services. The company was formerly known as BofI Holding, Inc. and changed its name to Axos Financial, Inc. in September 2018. Axos Financial, Inc. was incorporated in 1999 and is based in Las Vegas, Nevada.
Latest News
Why Is Vanguard S&P 500 ETF (VOO) Rising Today, 5/26/2026?
Canaccord Genuity Keeps Their Buy Rating on Arrow Exploration Corp (AXL)
Virax Biolabs Reports Strong Early Data for Long COVID Test and Prepares Larger Validation Study
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Eli Lilly & Co (LLY)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (BCAX), Abivax SA Sponsored ADR (ABVX) and Arcutis Biotherapeutics (ARQT)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AX | $87.38 | +1.5% | 65.41K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |